FranklinCovey FY 2026: Revenue $261.46M, EPS $0.42 — 10-K Summary

FranklinCovey reported FY 2026 revenue of $261.46M, down 2% YoY, while net income rose 60.5% to $4.92M. Education revenue increased 2% due to subscriptions, while Enterprise revenue fell 3%. Lower operating expenses and tax rates supported earnings growth, with EPS at $0.42.

Original reporting
Published Nov 12, 2026, 9:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FranklinCovey FY 2026: Revenue $261.46M, EPS $0.42 — 10-K Summary — source image
Decision brief

The 30-second read

$FCNeutralMed
01

Why it matters

The FY 2026 results highlight a shift toward subscription revenue in Education, offset by a decline in Enterprise deferred revenue, suggesting a transition in the business model.

02

Market read

The earnings release offers modest trading relevance for FC, with mixed signals that may cause short‑term price movement.

03

What to watch

The 10% subscription growth in Education may signal longer‑term tailwinds despite short‑term revenue pressure.

Relevance 6/10Novelty 6/10Timing: post‑market release

Background

FranklinCovey is a provider of training and consulting services, known for its "Leader in Me" program and subscription‑based education offerings.

Company-level read

Ticker impact

$FCNeutralHigh confidence
Context

FranklinCovey reported FY 2026 revenue of $261.46M, down 2%, and EPS of $0.42, up from $0.2475, in its 10‑K filing.

Expected impact

likely slight pressure as the market prices in the revenue decline despite EPS growth

Evidence & confidence

The primary disclosure of FY results is new information; the revenue decline is a negative catalyst, while the EPS increase is a positive offset, leading to modest net impact.

Market effects

Provides a data point for the education and enterprise training sector, showing modest growth in subscription revenue.

Limited to U.S. investors tracking small‑cap education services.

Low; the company is a niche player with minimal global footprint.

Counterpoint

Investors could view the EPS beat as a sign of operational leverage and consider buying on the dip.

Key entities

  • FranklinCovey

    Provider of training and consulting services; ticker FC.

Related articles

$FCMed

Franklin Covey (FC) Q4 2026 Earnings Call Transcript

Franklin Covey (FC) reported Q4 2026 growth in Enterprise North America, with invoiced amounts up 4% to $151.4M and deferred revenue up 17% to $59.2M. The company expects fiscal 2027 revenue and adjusted EBITDA growth, driven by a resilient core and successful go-to-market transformation. Education business is expected to return to growth, and AI trends support the company's durability.

$FCMed

Franklin Covey Co (FC) (Q4 2026) Earnings Call Highlights: Navigating Revenue Headwinds

Franklin Covey (FC) reported China as 2% of fiscal 2026 revenue, with a transition to a licensee model expected to reduce revenue by $2 million but remain EBITDA neutral. CFO Jesse guided to 45-50% of annual revenue in the first half of fiscal 2027, with restructuring savings increasing EBITDA through the year. CEO Paul Walker noted improved revenue retention and plans to expand the sales team by over 20%.

$FCMed

Franklin Covey Co. Q3 2026 Earnings Call Summary

Franklin Covey Co. reported Q3 2026 momentum driven by higher client retention/expansion and North America enterprise growth, including a third straight quarter of rising invoiced amounts. Services booking pace rose 25% YTD. Fiscal 2027 outlook calls for faster revenue growth and operating leverage, but revenue guidance was cut ~$6M due to timing, education budget, and geopolitical impacts; gross margin fell to 73.9% from 76.5%.

$FCMedAI 8/10

Why Franklin Covey Stock Plummeted Today

Franklin Covey (FC) shares fell 12.9% on Thursday after the company reported Q3 FY2026 results (ended May 31) below Wall Street expectations and issued weaker-than-expected forward guidance. EPS was $0.27 on sales of $67.8M vs estimates of about $0.31 on ~$68.3M revenue; guidance called for $260M–$267M sales vs prior $265M–$275M.